The fourth EFPIA/CPIA joint China/EU Pharmaceutical Industry Forum workshop will take place on Wednesday, 17 May 2017, in Shanghai, China.

The workshop covers a variety of regulatory and legal topics, and focuses principally on four different themes, including: Pharmaceuticals in the Environment; the Drug Administration Law (DAL) revision; coding and serialisation; and compliance (marketing ethics).

This event benefits furthermore from a wide range of experienced speakers from EFPIA, IFPMA and the European Commission:

Bengt Mattson, co-chair of the EFPIA Pharmaceutical in the Environment (PIE-TF) will give a presentation on Proposals from the European pharmaceutical industry on PIE, while the Assistant Director General of IFPMA, Brendan Shaw will showcase the IFPMA Code and explain how to set up a national, self-regulation system.

Mart Levo from the Estonian national medicines verification system REKS will outline existing rules and regulation on the Identification and authentication of medicines in Europe: “Opportunities and challenges to complying with EU legislation”. 

Pär Tellner, Team Leader, Drug Regulatory Affairs at EFPIA will act as moderator for the panel discussion and will offer the introductory speech to welcome delegates to the event.

The event will also feature a significant intervention from Patrick Deboyser, from the EU Commission’s Directorate General for Health (DG SANTÉ). Known as the "father" of the EU regulatory system for the authorisation of medicinal products, Mr Deboyser will offer a presentation on the EU system for marketing authorisations.  

Please see the final draft programme here.

For further details please contact: communications@efpia.eu